A 23-year-old female college student presents to the university health clinic for a routine wellness examination. She reports feeling well and has no specific complaints. Her medical history is unremarkable, and she currently takes an oral contraceptive pill daily. She mentions that she recently became sexually active with a new male partner. Review of her immunization records confirms she completed the human papillomavirus (HPV) vaccine series at age 12. According to current United States Preventive Services Task Force (USPSTF) guidelines, which of the following screening interventions are indicated for this patient during today's visit? (Select all that apply)
- Cervical cytology aloneAnswer
- Nucleic acid amplification testing for Chlamydia trachomatis and Neisseria gonorrhoeaeAnswer
- CHigh-risk human papillomavirus (hrHPV) testing
- DSerologic testing for herpes simplex virus type 2
- ERoutine transvaginal ultrasonography for ovarian cancer screening
Answer
The indicated interventions are cervical cytology alone and nucleic acid amplification testing for Chlamydia trachomatis and Neisseria gonorrhoeae.
The patient is a sexually active 23-year-old female. According to USPSTF guidelines, sexually active women under the age of 25 should be screened annually for Chlamydia trachomatis and Neisseria gonorrhoeae (Grade B recommendation). Additionally, routine cervical cancer screening begins at age 21, and for women aged 21 to 29, the recommendation is screening every 3 years with cervical cytology alone (Grade A recommendation). Both of these interventions directly apply to this patient's presentation.
Step-by-Step Solution
Key Concept
Preventive screening guidelines for sexually active young adult females